: Pfizer submits a new NDA to FDA for COVID-19 pill PAXLOVID #FinanceUSA #StockMarketNEWS Pfizer Inc. said Thursday that it has submitted a New Drug Application (NDA) for COVID-19 treatment pills PAXLOVID
@stockMarketNEWS Fri 01 Jul, 2022
Pfizer submits a new NDA to FDA for COVID-19 pill PAXLOVID #FinanceUSA #StockMarketNEWS
Pfizer Inc. said Thursday that it has submitted a New Drug Application (NDA) for COVID-19 treatment pills PAXLOVID for patients at high risk for progression to severe illness. PAXLOVID has previously been granted Emergency Use Authorization (EUA) for treatment of mild-to-moderate COVID-19. The drug maker said the NDA submission provides longer-term follow-up data needed for potential approval. "Data from our clinical development program, coupled with the more than 1.7 million patients around the world who have been prescribed our oral treatment to date, reinforce PAXLOVID as an important treatment option for mild-to-moderate COVID-19 in patients at greater risk of progression to severe symptoms, regardless of vaccination status," said Pfizer Chief Executive Albert Bourla. The stock, which slipped 0.6% in premarket trading, has lost 13.7% year to date through Wednesday, while the S&P 500 has climbed 19.9%.
Munafa USA Munafa India Munafa NSE
More posts by @stockMarketNEWS
: Universal Health stock tumbles after profit warning, given 'shortfall' in patient volumes #FinanceUSA #StockMarketNEWS Shares of Universal Health Services Inc. tumbled 8.6% toward a two-year low
@stockMarketNEWS Fri 01 Jul, 2022
: Walgreens beats Street views but sees sharp profit decline #FinanceUSA #StockMarketNEWS Walgreens Boots Alliance Inc. reported third-fiscal-quarter net income totaling 9 million, or 33 cents per
@stockMarketNEWS Fri 01 Jul, 2022
0 Comments
Sorted by latest first Latest Oldest Best